{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:48:58Z","timestamp":1697230138584},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1006\/mcpr.2001.0348","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:43Z","timestamp":1032378403000},"page":"99-103","source":"Crossref","is-referenced-by-count":4,"title":["Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR"],"prefix":"10.1006","volume":"15","author":[{"given":"A.","family":"Lal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mcpr.2001.0348_RF1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute Lymphoblastic Leukaemia","volume":"339","author":"Pui","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1006\/mcpr.2001.0348_RF2","first-page":"489","article-title":"Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan","volume":"18","author":"Carpenter","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1006\/mcpr.2001.0348_RF3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(94)90988-1","article-title":"Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual \u00cddisease at the end of induction","volume":"343","author":"Brisco","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/mcpr.2001.0348_RF4","first-page":"1779","article-title":"Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers","volume":"9","author":"Norris","year":"1995","journal-title":"Leukemia"},{"key":"10.1006\/mcpr.2001.0348_RF5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cave","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1006\/mcpr.2001.0348_RF6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/mcpr.2001.0348_RF7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM199701303360501","article-title":"Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia","volume":"336","author":"Roberts","year":"1997","journal-title":"New \u00cdEngland Journal of Medicine"},{"key":"10.1006\/mcpr.2001.0348_RF8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2141.1997.3723186.x","article-title":"Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia","volume":"99","author":"Brisco","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1006\/mcpr.2001.0348_RF9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V77.2.331.331","article-title":"Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic \u00cdleukemia patients","volume":"77","author":"Yokota","year":"1991","journal-title":"Blood"},{"key":"10.1006\/mcpr.2001.0348_RF10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01715137","article-title":"In patients with BCR-ABL-positive ALL in CR peripheral blood contains less residual disease than bone marrow: \u00cdimplications for autologous BMT","volume":"68","author":"Martin","year":"1994","journal-title":"Annals of Hematology"}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850801903482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850801903482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T22:58:41Z","timestamp":1576537121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850801903482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0890850801903482"],"URL":"https:\/\/doi.org\/10.1006\/mcpr.2001.0348","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}